z-logo
open-access-imgOpen Access
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603)
Author(s) -
E. M. O'Reilly,
D. Niedzwiecki,
M. Hall,
D. Hollis,
T. Bekaii-Saab,
T. Pluard,
K. Douglas,
G. K. Abou-Alfa,
H. L. Kindler,
R. L. Schilsky,
R. M. Goldberg
Publication year - 2010
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/dwx2-9n84
Subject(s) - sunitinib malate , medicine , pancreatic cancer , sunitinib , cancer , oncology , adenocarcinoma , leukemia , group b

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom